Leukocytosis is linked to thrombosis at diagnosis, while JAK2 V617F mutation is associated with thrombosis during the course of essential thrombocythemia-Reference-Cited by-同舟云学术

Leukocytosis is linked to thrombosis at diagnosis, while JAK2 V617F mutation is associated with thrombosis during the course of essential thrombocythemia

Published:2008-04-15 Issue:4 Volume:87 Page:446-448
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Ohyashiki Kazuma,Kiguchi Toru,Ito Yoshikazu,Fujimoto Hiroaki,Gotoh Akihiko,Tauchi Tetsuzo,Miyazawa Keisuke,Kimura Yukihiko,Ohyashiki Junko H.

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-008-0080-9.pdf

Reference9 articles.

1. Campbell PJ, Scott LM, Buck G, et al. Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study. Lancet. 2005;366:1945–53.

2. James C, Ugo V, Le Couédic J-P, Staerk J, Delhoummeau F, Flacount C, et al. A unique clonal JAK2 mutation leading to constitutive signaling causes polycythemia vera. Nature. 2005;434:1144–8.

3. Ohyashiki K, Aota Y, Akahane D, Gotoh A, Ohyashiki JH. JAK2V617F mutational status as determined by semiquantitative sequence-specific primer-single molecule fluorescence detection assay is linked to clinical features in chronic myeloproliferative disorders. Leukemia. 2007;21:1097–9.

4. Ohyashiki K, Ito Y, Hori K, Sato K, Makino T, Ohyashiki JH. Thrombosis can occur at any phase of essential thrombocythemia with JAK2V617F mutation: a single institutional study in Japan. Leukemia. 2007;21:1570–1.

5. Finazzi G, Rambaldi A, Guerini V, Carobbio A, Barbui T. Risk of thrombosis in patients with essential thrombocythemia and polycythemia vera according to JAK2 V617F mutation status. Haematologica. 2007;92:135–6.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Genetics of Thrombotic Myeloproliferative Neoplasms: Implications in Precision Oncology;Diagnostics;2023-01-03

2. Molecular genetics of thrombotic myeloproliferative neoplasms: Implications in precision oncology;Genes & Diseases;2021-01

3. Leukocytosis and thrombosis in essential thrombocythemia and polycythemia vera: a systematic review and meta-analysis;Blood Advances;2019-06-07

4. Emergence of chronic myelogenous leukemia during treatment for essential thrombocythemia;International Journal of Hematology;2010-02-11

5. Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: A systematic review;Thrombosis Research;2009-09